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Abstract 
Although sociological studies of quality and safety have identified competing epistemologies 
in the attempt to measure and improve care, there are gaps in our understanding of how 
finance and accounting practices are being used to organise this field. This analysis draws on 
what others have elsewhere called ‘financialisation’ in order to explore the quantification of 
qualitatively complex care practices. We make our argument using ethnographic data of a 
quality improvement program for acute kidney injury (AKI) in a publicly funded hospital in 
England. Our paper is thus concerned with tracing the effects of financialisation in the 
emergence and assembly of AKI as an object of concern within the hospital. We describe 
three linked mechanisms through which this occurs: (1) representing and intervening in 
kidney care; (2) making caring practices count; and, (3) decision-making using kidney 
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numbers. Together these stages transform care practices first into risks and then from risks 
into costs. We argue that this calculative process reinforces a separation between practice, 
and organisational decision-making made on the basis of numbers. This elevates the status of 
numbers while diminishing the work of practitioners and managers. We conclude by 
signalling possible future avenues of research that can take up these processes.   
Introduction 
In the wake of the 2008 credit and sovereign debt crises, scholars have sought to understand 
how financial concerns increasingly shape economies and states (Guillén and Suárez, 2010, 
Perrow, 2010, Stiglitz, 2010). It is retrospectively argued that the process now known as 
‘financialisation’ can be traced back to the 1960s crises of state, experienced first in the US, 
then spreading to the UK, parts of Europe and Australia over the next decade. At this time, 
excessive government debt, balance of payment problems and incompatible social demands 
led to a loss of public confidence in the state’s ability to manage these problems (Krippner, 
2012). In response, conventional paradigms of public administration gave way to ‘new’ 
managerial discourses (Hood, 1991, Hoggett, 1996, Pollitt et al., 1991). Various forms of 
marketisation were also promulgated to purportedly increase efficiency, flexibility, and 
liberation from bureaucratic ties (e.g. Clegg et al., 2011). Sociological literature that focuses 
on health care, provides rich descriptions of these processes and draws our attention to the 
various effects of management and markets upon practices and processes of care (e.g. Mol, 
2008, Moreira, 2013), as well as upon the work, identities and ethics of health practitioners 
and managers (e.g. Waring and Currie, 2009, Noordegraaf, 2011). Financialisation finds its 
roots in these same processes but it disturbs the conventional coupling of management and 
markets, resulting in organisational practices that exceed our extant understandings of 
managerialism in healthcare and other public sectors. Similarly, while the production and 
circulation of numbers has been shown to be an important part of a neo-liberal apparatus of 
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government (Hacking, 1990, Rose, 1999), financialisation encourages us to look at the 
specifically financial character of politicisation that we find in contemporary modes of 
government, as this shapes decisions about the kind of numbers to produce and the purposes 
to which they are put.   
In this paper, we build on the public sector financialisation literature (du Gay et al., 2012, 
Froud et al., 2009) to draw attention to the processes of abstraction, measurement, and 
tabulation which are generated in qualitative knowledge practices through the deployment of 
technologies and programmes ostensibly concerned with patient safety and quality 
improvement. Our argument seeks to extend existing sociological enquiry into one of the 
dilemmas of quality and safety practice: epistemologies which abstract and concretise in an 
attempt to reduce everyday complexity and make it measurable (Waring, 2013). Following 
Waring (2009), we are interested in how this process results in the generation of ‘socio-
cultural and political dynamics of organisational life’ that can be analysed in order to better 
understand the practices they shape. Financialisation provides an underpinning logic to this 
process, but it also alerts us to a set of problems to do with the detachment of quantitative 
measures from the qualitative practices out of which they are generated, and the effect this 
has in situating an alternative way of thinking and doing within practice. In our argument, 
financialisation—through new organisational technologies which map, quantify and 
automate—brings into effect a set of organisational arrangements for establishing debt and 
investment. Numbers can then displace, or hijack, other kinds of values such as quality or 
safety. Our focus on the relationship between what we refer to as ‘qualitative’ knowledge and 
practice, which we contrast with the ‘quantitative’ bundling of these practices, is part of an 
attempt to demonstrate how numbers are created and become authoritative with regards to the 
practices out of which they are produced. This effects what we refer to as an organised 
separation between the domain of healthcare practices and the numbers assembled in those 
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practices, with the qualitative domain not only reduced via its abstraction to the quantitative, 
but also diminished within that domain due to the status of numbers as ‘undisputed future 
projections’ (Mazmanian and Beckman, 2018). Financialisation is becoming a more 
mainstream term within studies of political economy, however, it is still on the margins of 
sociological discourse and to date there is only a single sociological study of financialisation 
in health care, which examines the effects of private equity funds in the Turkish health 
system (Vural, 2017). The organisation of these processes within publicly funded health 
systems has not yet been subjected to scrutiny within the medical sociological research 
literature. 
We draw on ethnographic data from a study of a quality improvement (QI) program in an 
acute hospital trust providing specialist renal services in the National Health Service (NHS) 
in England, in order to set up a broader discussion of financialisation in healthcare. The data 
set reported here comprises observational, interview and documentary data collected over a 
period of approximately two years. The data was generated during the set up and 
implementation of a QI program for Acute Kidney Injury (AKI), a syndrome characterised by 
a sudden reduction in kidney function.  
In 2014-15, the national commissioning body for the NHS in England promoted the 
organisational attention given to AKI through two programmes: first, they issued a patient 
safety alert which mandated the introduction of an algorithm into all NHS laboratories, to 
standardise the identification of AKI (NHS England, 2014); second, they launched a twelve 
month incentive programme, which was aimed at improving the information recorded and 
documented about AKI on patient discharge summaries (NHS England, 2015). These two 
programmes shaped the core focus of the QI work undertaken in our empirical site. They also 
signalled to us two different ways in which qualitative practices could be rendered smooth 
and calculable. Our task then became one of seeing, firstly, how this calculus-like logic could 
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take hold within a domain governed by the knowledge practices of medical experts (Aveling 
et al., 2016), secondly, through what ‘frictions and flows’ the translation of qualitative into 
quantitative could take place (Fiore-Silfvast, 2014), and lastly, the effects of this 
transformation upon the decisions and actions of the managers and professionals responsible 
for its implementation, and whose work is consequently ‘taken into account’ (Allen, 2016).    
We argue that once these translations have occurred, the generated numbers become 
organisationally detached from the ethical, social and political aspects of experience out of 
which they were assembled, yet they continue to participate in that experience, but on new 
terms. By subsequently forming the basis of financial decision making within and across 
organisations, these numbers end up bearing down on the very practices out of which they 
were produced. To build this argument we describe three processes from our empirical 
research: (1) representing and intervening in kidney care; (2) making caring practices count; 
and, (3) decision-making using kidney numbers. This three-part mechanism is one in which 
care practices are rendered problematic and worked upon through organisational technologies 
which map, quantify and automate. The assumptions embedded in the attempt to make 
practice calculable, is that it can be made predictable, and in a sense perfectable. Working 
with these assumptions, it becomes possible to rate care practices according to their states of 
non-compliance and to control them on new terms.  
Financialisation represents a new frontier for exercising organisational control in public 
organisations, created by a shift in the activities of frontline practitioners and managers 
towards the assembly and maintenance of financial numbers. Through ethnographic data we  
attend to the means by which ‘quality’, ‘safety’ and ‘improvement’ find expression within 
daily care practices through the mobilisation of specific mechanisms for each process we 
describe. In our study of AKI these are operationally achieved through the introduction of 
methods and materials of improvement such as process mapping, algorithms, electronic 
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patient records and incentive payments. These methods and materials are in common use in 
improvement programmes in health services internationally, underscored by strong 
institutional support (e.g. Institute of Healthcare Improvement, 2003). Our interest in these 
organisational technologies is the work they do in bringing into effect a new decision-making 
repertoire for interrogating practice using numbers that participate in debt and investment. 
This extends research on commodification in healthcare, for example through pay for 
performance frameworks (Checkland et al., 2007, Norman et al., 2016) because it sets up a 
future financial state of affairs and establishes debt relations between this anticipatory future 
and everyday practice, alongside an apparatus for measuring and recording practice 
‘improvement’. Together these mechanisms enact a series of translations, from care to risk 
and from risk to cost. The process involves the separation of numbers from the knowledge 
practices that have produced them and a subsequent relocation of these numbers to a different 
domain. In this new location, these numbers can then accomplish two kinds of work: 
intervening ‘back’ upon and shaping care practices, and presenting public accounts of the 
organisation, by being mobilised ‘out’ in order to shape future decisions made by and on 
behalf of the organisation. In a context of austerity, such decisions can threaten the 
organisation’s very existence. In this same vein, financialisation effects a shift in extant 
understandings of managerialism in public organisation (e.g. Ferlie et al., 1996). As numbers 
are separated from practices, the activities of frontline practitioners, managers and other 
skilled knowledge workers increasingly focus on the maintenance of those numbers which 
uphold organisational narratives (Cushen, 2013), simultaneously eclipsing everyday struggles 
to create and maintain improvement.  
To introduce financialisation to medical sociology we begin with a detailed description of it 
as a concept. We first situate it in the macro economic conditions of the 1970s. Then we 
outline its relationship to neoliberalism and public policy, before moving towards meso and 
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micro-level financialisation and the production of numbers through the work of frontline 
practitioners and managers, where our own analysis begins. 
Financialisation in economy, society and (public) organisation 
Financialisation is a term used to describe the ‘increasing role of financial motives, financial 
markets, financial actors and financial institutions in the operation of the domestic and 
international economies’ (Epstein, 2005). This increasing role signals a shift in the meaning 
and consequences of accumulation and value in capitalist systems. Finance has always played 
an important part in capitalist systems of accumulation, as the source of capital through 
which productive capacity could be increased and from which greater profit could be derived. 
This role is embedded in capitalism through the circulation of commodities, money and 
credit. The vastly expanded role of finance observed in Anglo-American and latterly global 
capitalism since the 1970s marks a deepening and broadening of this embedding (Fine, 
2010). This has led to the proliferation of increasingly complex and future-oriented derivative 
forms of finance, described collectively as ‘fictitious capital’ (Haiven, 2014). The result is a 
shift away from production as the heart of capitalist accumulation through the ‘elimination of 
productive capacity and employment’ (Rossman and Greenfield, 2006), with profit no longer 
derived from growth in the fixed capital means of production, but from the extraction of 
value, specifically shareholder value. Ownership then no longer means controlling the means 
of production, as a Marxist analysis would have it, but instead control of technology and 
information which guides short-term financial restructuring and outsourcing to maximise 
returns, hence Lazonick & Sullivan’s (2000) claim that the modus operandi of capitalism has 
shifted under financialisation from ‘retain and reinvest’ to ‘downsize and distribute’. This 
signals a shift from value creation to ‘value capture’ (Krippner, 2005), with companies 
reduced to a ‘bundle of assets’ to be traded (Froud and Williams, 2007). 
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Although it is recognised that financialisation does not represent a single or unitary ‘logic’, 
nevertheless there is a broad consensus over both the conditions that have led to, and the 
consequences of, the contemporary experience of financialisation (Froud et al., 2007). 
Initiated by the policy response to the U.S dollar crisis in the 1970s, financialisation took root 
in the new possiblities created by international currency trading and the ‘floating’ exchange 
rate (D’Arista, 2005).  
In the UK, the experience of financialisation is intimately tied to neo-liberalism, as the 
political polarisation that was caused by the economic decline of the 1970s eventually 
resulted in the election of the Conservative Government in 1979, which led to the 
implementation of a radical agenda, beginning with ‘experiments with privatisation and 
deregulation, supply side policies and aspirations for a smaller state’ (Gamble, 2009). 
Deregulation had the effect of expanding the scale and scope of markets for currency futures, 
which then moved into derivatives, leading in turn to the rise of ‘pension fund capitalism’ and 
a ‘revolution in retail banking’, which turned citizens into (somewhat unwitting) consumers 
of financial products (Froud et al., 2007). The neo-liberal values of privatisation and self-
responsibility therefore find their monetary expression in financialisation; thus 
finanicalisation becomes the individual pursuit of self-interest as the means to (financial) 
freedom (Langley, 2004, c.f. Rose, 1999). This demands ‘new identities and forms of 
calculation’ from citizens, without the knowledge and technology with which to make 
‘sensible choices’ (Froud et al., 2007). 
Nevertheless, the relationship between financialisation and neo-liberalism is a complex one, 
and this can be examined through the changing role of the state vis-à-vis the market. As the 
financial sector comes to dominate the productive sector, national economic sovereignty is 
undermined and a marketisation of financial relations leads to the ‘disembedding of global 
finance from national programmes of governance’ (Froud et al., 2007). This undermines the 
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role of the state as an active agent of economic restructuring; hence the neo-liberal 
relationship between financial deregulation and the shrinking role of the state. In turn, the 
role of the state in social policy and welfare is eroded. At the same time the state becomes an 
active agent of finance capitalism; beginning in the 1970s, as noted above, there is state 
intervention through economic policy that promotes the interests of private capital and 
financial markets. This is what Fine (2010) refers to as the ‘first phase’ of financialised neo-
liberalism. The second phase is marked by state intervention to ‘moderate the negative impact 
of finanicalisation’ (Fine, 2010). This began with the credit crisis of 2007 which precipitated 
the sovereign debt crisis caused by the public bail out, first of Northern Rock and 
subsequently of RBS, HBOS and Lloyds. For some, this represents a shift away from one 
strand of neo liberalism in the retention of a strong (albeit altered) state role in economy and 
society, for others it represents the enrolment of the state as a mediator of global financial 
interests through domestic economic and social policy (Fine, 2010, Fine, 2012). 
The cross-party neo-liberal consensus that can be observed through the trajectory of public 
policy in the UK over the past three to four decades has become fused in the contemporary 
experience with the sovereign debt crisis. This has diverse consequences; most obviously 
austerity spending, privatisation and outsourcing, but also de-politicisation through the 
creation of semi-autonomous and ‘arms-length’ regulatory bodies and quasi-corporate 
structures, and the dissemination of investment and incentive schemes which act as ‘hinges’ 
through which the interests of private capital can access the balance sheets of public 
organisations directly (du Gay et al., 2012). 
Studies of financialisation at the organisational level have emphasised the role of strategic 
narratives produced between top management and external financial actors in order to 
construct future-oriented stories of value creation (Erturk et al., 2008, Froud et al., 2006). 
Management narratives are optimistic and characterise the organisation as pursuing strategies 
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through which to achieve future returns. These narratives shape and are shaped by the 
valuation and investment decisions of other actors, creating a sense of order and stability in 
the inherently uncertain and unstable financial market. The task of senior management is then 
to ensure that there are numbers with which to corroborate narratives (Hendry et al., 2006). 
Extending this position, Cushen (2013) argues that financialisation at the micro level is 
‘defined precisely by the stream of performative interventions organisations take to live the 
narrative’. Narrative construction empowers senior management to set their own performance 
targets, which are then ‘sold’ to ‘the market’ (Hendry et al., 2006). Further down the 
hierarchy the task of managers and other knowledge workers becomes a practice of 
assembling the numbers in order to maintain the narrative (Cushen, 2013). This elevates the 
role of accounting in organisations and at the micro level brings into view techniques and 
practices of accounting (Bresnen et al., 2017). These techniques and practices are not neutral 
or value-free but rather, represent the attempt to ‘quantify and compare things which, by their 
very nature, are neither quantifiable nor directly comparable’ (Perry and Nölke, 2006). This is 
the core concern we explore through our ethnographic data. We examine how financial 
projections and narratives play a key role in the representation and problematisation of 
practices, which are transformed first into risks, and then into costs. 
Acute Kidney Injury 
Our paper draws on ethnographic data from a study of a quality improvement (QI) 
programme for Acute Kidney Injury (AKI) in an acute hospital providing specialist renal 
services for an urban population of around 1.5 million people. AKI is a syndrome 
characterised by sudden and potentially lethal damage to the kidneys, often as a secondary 
product of infection, dehydration, or medication, which affects between 5-15% of all hospital 
admissions in England (Kerr et al., 2014). The problems that are now associated with the 
 11 
term ‘AKI’ were first identified from autopsies of wounded soldiers in World War Two and 
furthered through observations made during the Korean war, which concluded that post-
traumatic renal inefficiency was a major cause of death among the severely wounded 
(Bywaters and Beall, 1941, Teschan et al., 1955). The term AKI is more recent, having first 
been described in 2004 as part of an attempt to generate consensus over the clinical definition 
and diagnostic criteria for acute renal failure (Bellomo et al., 2004). It is only in the wake of a 
highly critical report by the National Confidential Enquiry into Patient Outcome and Death 
(NCEPOD, 2009), subsequent national and international guidelines (NICE, 2013, KDIGO, 
2012), and an economic analysis suggesting substantial underestimation of the prevalence 
and cost of AKI (Kerr et al., 2014), that AKI has emerged as an improvement priority for 
English health care organisations. 
In 2014, the national NHS commissioning body issued a patient safety alert aimed at 
standardising the early identification of AKI. It mandated, within all NHS laboratories, the 
introduction of an algorithm which would identify potential cases of AKI from laboratory 
data, and produce a result which could then be communicated through IT patient management 
systems. All lab systems were expected to ‘go live’ by March 2015. At the same time, NHS 
England put out a commissioning directive for AKI known as a CQUIN (Commissioning for 
Quality Improvement, hereafter; incentive scheme), which sets out particular conditions that 
if satisfied by the organisation adopting them results in a bonus payment. The AKI incentive 
scheme (NHS England, 2015) required that patient discharge summaries include four items: 
1. Stage of AKI (a key aspect of AKI diagnosis); 
2. Evidence of medicines review having been undertaken (a key aspect of AKI 
treatment); 
3. Type of blood tests required on discharge for monitoring (a key aspect of post 
discharge care); 
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4. Frequency of blood tests required on discharge for monitoring (a key aspect of post 
discharge care) 
These incentive schemess are not mandatory, and the organisations adopting them can fix 
their own targets and compliance levels within given parameters. 
Research Methods 
Our study was part of a larger project which sought to use ethnographic methods to explore 
in-depth the implementation and spread of QI programmes related to AKI in secondary care. 
The broader aim was to develop a nuanced organisational account of the nature and role of 
context in QI programmes, by examining the material accomplishment of key values such as 
‘quality’, ‘improvement’, and ‘safety’, also attending to ways in which the often informal 
work of improvement could be made more visible. 
The study was set up and funded as part of the National Institute of Health Research (NIHR) 
Collaboration for Leadership in Health Research and Care (CLAHRC) program. CLAHRCs 
are research networks involving close partnerships between research and practice in the NHS. 
The trust in which our study took place was an existing partner of the network, and the study 
scope emerged from a series of conversations between the researchers and the quality 
improvement team in the trust initiated in March 2015. The protocol was agreed, and internal 
ethical review was completed in July 2015, at which point the research team started 
observing programme meetings. A full ethics application was also initiated at this time and 
received a favourable opinion from the Wales 7 REC committee (15/WA/0400, 16th 
November 2015).  
The data set comprises observational, interview and documentary data collected over a period 
of 24 months. The data was generated during the planning, set up and implementation of the 
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first phase of the QI program and the incentive scheme implementation period. At the 
conclusion of data collection the program had completed the first ‘initiation’ phase and had 
started the second, ‘spreading’ phase. 
Observations were made of meetings and other events associated with the QI programme 
itself as well as time spent observing routine activities on wards. The programme itself was 
made up of a series of learning events (one whole day and four half day events over a 12 
month period), attended by representatives of each of the eleven wards involved in the 
programme. These learning sessions were comprised of three main elements: (1) Learning 
about improvement methodology; (2) Learning about acute kidney injury; and, (3) Setting 
and monitoring targets for improvement. Over time, the emphasis shifted towards the 
ongoing monitoring of targets, which occurred partly through the statistical run-charts 
displayed presentation-style by one of the QI team, and partly through the more interactive 
development of ‘tests of change’ (see ‘Quality Improvement Methodology’, below). These 
tests were then tried out through routine activities on the wards, fed back to subsequent 
learning sessions, and refined over time. 
In addition to the learning sessions for the QI programme, regular meetings were observed 
involving members of the QI team along with a wider steering group made up of key clinical 
and managerial staff from across the hospital, including divisional management, IT 
specialists, acute, surgical and renal consultants, and learning and development coordinators. 
This group met on average approximately once per month throughout our study. 
Interviews were conducted with members of the three main groups that comprised the 
improvement work in the hospital: the QI team, the steering group and the clinical teams 
participating in the QI programme. Interview schedules were unstructured and were intended 
to elaborate upon themes identified through the ongoing observational work. 
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Quality Improvement Methodology 
The trust we describe here had a specific directorate responsible for QI, which had adopted 
the Institute of Health Improvement’s ‘break through series’ (BTS) approach to QI. This is a 
collaborative approach which aims to achieve sustainable improvement through ‘culture 
change’ (Institute of Healthcare Improvement, 2003). Programmes are made up of a series of 
learning sets which involve front line workers from across relevant wards and departments, 
usually around four sessions over a 1-year period. During these sessions staff are instructed in  
improvement methodology, which draws on a systems approach to organisation and 
management, informed particularly by safety science. Staff are then asked to design ‘tests of 
change’ through which they aim to make improvements in their respective wards and 
departments. In between each learning session these ‘tests’ are carried out and the results and 
reflections brought to the next learning session. The overall objective of the learning sessions 
and tests of change is to generate a ‘change package’, with concrete steps for the achievement 
of the desired change, which can then be spread within and across the relevant wards and 
departments. The hospital had also adopted the incentive scheme for AKI, and from March 
2015 onwards had to submit quarterly data excerpts to NHS England. In contrast to the 
collaborative and developmental approach of the QI programme, the incentive scheme was 
seen by the programme managers as a ‘top down’ and ‘tick box’ exercise. 
AKI is understood in national and international policy and guidance as a safety problem, with 
improvement aimed at reduction in preventable harm. Although safety has been a core 
concern of organised medicine for many years, it has risen to prominence in the past two 
decades, and has become almost synonymous with the idea of quality – such that quality in 
health care can be measured as compliance with standardised tools and methods such as 
checklists and audits (Waring et al., 2016). This doctrine reached a kind of zenith in the 
dissemination by the leading US Institute of Health Improvement of what it called the ‘triple 
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aims’, according to which all QI programmes should simultaneously strive to achieve 
improvements in ‘care, health and cost’ (Berwick et al., 2008). Via the doctrine of safety, 
quality in health care therefore becomes intimately tied with waste and efficiency. Under 
austerity this increasingly becomes pecuniary efficiency. 
The QI programme we observed took place in a context that faced extreme pressures due to 
the austerity spending programme first implemented in 2010, which continues to the present. 
Over the period of our observations within the hospital, the QI team faced a constant battle 
attempting to engage staff in the program, when this meant leaving shortages on wards which 
had experienced severe reductions in staffing numbers amid rising levels of demand. It is 
within this context that the promise of a syndrome like AKI, with its preventable harms, cost 
savings and incentive schemes, is made an attractive object of intervention. However, 
intervention on these terms resulted in a close and problematic coupling of QI with cost 
saving, which created ongoing management challenges throughout the duration of the 
programme. 
Findings 
Representing and intervening in kidney care 
The formation of the object AKI requires the context in which AKI is experienced to first be 
made visible in a way which renders the everyday, tacit experience of the organisation 
problematic. We draw on the empirical example of process mapping to illustrate this. Process 
mapping was part of the initial setup of the quality and safety program. It was initiated by the 
QI team. The objective of the process map was to develop a visual representation of what 
happens to a patient upon entering the clinical area or ward being mapped. On this occasion, 
the area being mapped was the Emergency Assessment Unit (EAU). In the following excerpt, 
the EAU manager began facilitating the process mapping in the absence of the QI manager 
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who had not yet arrived. An EAU consultant was present, as were three or four ward staff – 
nurses and health care assistants. 
The mapping proceeds with the manager asking prompting questions and then writing 
down the responses of the clinical staff on coloured notes and sticking them on a 
white board to make the map. The manager opens with the question and then follows 
up responses with further prompts, in the following manner (Note; not verbatim 
transcript): 
Q: How do AKI patients get onto the system 
A: Elective or emergency admissions. 
Q: Where do emergency admissions come from 
A: A&E, primary care, EAU, specialist referral 
Q: Tell me about EAU 
A: All patients are seen and assessed, and a risk assessment is carried out 
Q: What factors are considered? 
A: Depends on the patient, and the kind of admission, there are many different 
possible risk factors you might look at. 
Q: What happens next? 
A: Bloods are taken 
Q: And sent to biochemistry? 
A: Not always, depends on severity 
 
At this point the exercise was less than 5 minutes old, and there was a lot of discussion, and 
some debate and confusion about how the sticky notes should be placed in relation to one 
another. Some problems challenged the format of the sticky notes, some elements of the care 
process, such as the risk assessment that took place when patients first entered EAU, were too 
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multifactorial and context dependent to be represented in this way. It was not practical to 
have a different note for each different possible risk factor, and yet, different risks prompted 
different possible actions. The ideal of the linear pathway that can be mapped was being 
challenged. The exercise continued: 
Around this time a QI manager [hereon; Q1] came in. Q1 looked at the map and 
made a circumspect noise, which suggested to me that he felt the exercise wasn’t 
taking shape in the way he hoped. So he took over and began with a new starting 
point, rather than starting from the beginning and saying ‘what happens when a 
patient enters the unit’, he flipped the process around and started with the desired 
outcome (the incentive scheme criteria for the discharge summary), and then asked 
the staff to think about the necessary steps that need to be in place in order to deliver 
this outcome. Q1 wrote down the incentive scheme criteria, and reminded everyone 
that 90% compliance was required, then wrote up a template set of prompts that 
needed to be answered at each stage of the map: 
1. What needs to be done? 
2. Who by? 
3. What needs documenting? 
Returning to the map, Q1 started with the note that said ‘bloods taken’: 
 Q: What happens after bloods are taken 
A: The report comes back with the stage of AKI. Stage 1 or 2 are routine 
reports 
 Q: What happens to these? 
A: The result goes on the EPR [electronic patient record] 
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Q1 puts a note up saying ‘AKI result on EPR’ and next to it puts a bright 
yellow note saying ‘incentive scheme (1)’. 
Q: What happens to the 3s? 
A: Flagged for biochemistry 
Q: What does that mean? 
A: The result is telephoned through to biochemistry 
Q: Who answers the phone? 
A: There isn’t a dedicated member of staff to answer the phone 
Q: What if no one answers? 
A: We try again 
Q1 puts a bright red note next to ‘flag for biochemistry’ which says: ‘Risk: 
delay, telephone unmanned’, then returns to the previous stage: 
Q: AKI result on EPR – who is aware of this? Are people looking for AKI 
results? (Another ‘risk’ note goes up) 
 
This kind of dialogue continued for approximately 20 minutes, by which time there 
were several ‘risk’ notes. Many of these related to the transfer of information between 
staff, and the actions which were prompted on the basis of information. Information 
transfer seemed to happen as part of the ‘everyday’ and it was not easy to systematise 
in the way the process mapping demanded. Where an action was required, there were 
usually several possible actions that could be taken depending on other variables. In 
these instances Q1 prompted for further information, and created new notes with 
more ‘risks’ as well as ‘actions’ required in order to improve the automatic prompts 
and flags that could appear on the EPR, in order to guide decision making. Q1 
finished by asking the divisional manager to lead a process whereby all risks were 
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collected together and an action plan made for each one. Q1 reminded everyone to 
think about the standard that is required (the incentive scheme and 90% compliance) 
and the three prompts that need to go with each action. 
 
Process mapping mobilises a metaphor of the map and the journey which attempts to render 
events in a topographical and linear format. In the above encounter, the messy and tacit 
everyday process challenged this form of representation. Upon taking over, Q1 inverted the 
process, instead of starting with the patient and their entry to the unit, it now started with the 
desired outcome. To continue the metaphor of a journey, the mapping began with the 
destination and limited all possible routes according to this. This move naturalised the 
metaphor of the linear journey and instead made the everyday tacit process problematic. The 
actualisation of problems was documented according to specific ‘risks’ and ‘actions’ required 
for their amelioration. The process then created the possibility of ordering and ranking 
different clinical areas according to ‘riskiness’. It also highlighted areas in which more 
specific prompts for action were required. This brings us to our focus in the next section on 
the devices which could translate the process of ‘representing and intervening’ that we have 
just described into subsequent action. The inversion involved in this interrogation of practice 
according to a naturalised future becomes an important adjunct to financialisation, to which 
we will return in the final empirical section. 
 
Making caring practices count  
In the process mapping, a situation was made problematic when the transfer of information, 
and actions following that transfer, were too dependent on the situated judgement and 
interaction of individuals. One of the tasks of the QI programme was to reduce the 
dependence on human initiated data generation and transfer. There were two technologies 
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that were central to this attempt; the algorithm producing an electronic alert for AKI, and the 
electronic patient record (EPR). 
When routine blood work was sent to pathology, the algorithm produced an AKI alert if there 
was a measurable change in the levels of serum creatinine, a by-product of normal muscle 
metabolism, from baseline – the degree of change is represented as AKI stage one, two or 
three. The baseline is taken from previous blood results. Only if there is a previous blood 
result on record can the calculation be made and the alert produced. Where there is no prior 
result, recorded staff are required to find a baseline by searching manually through a patient’s 
notes and following up with either a hospital where they have previously been admitted, or 
with their General Practitioner (GP), or by estimating on the basis of population data.  
In addition to this reliance on data which might not be there, the algorithm also relies on 
human interaction and interpretation. It alerts staff only to the presence of an individual who 
is ‘at risk of’ developing AKI stage one, two or three. The alert does not substitute human 
work but requires and directs it. Qualitative judgement is required to interpret this result in 
the context of the specific circumstances of the case, and to make an appropriate decision. 
Because of the reliance on the baseline data, and the syndromic nature of AKI, the alert is a 
crude judgement, and is associated with both the problem of over and under alerting.  
The imprecision of the technology, the dependence on pre-existing data, and the qualitative 
judgement of professionals, demonstrate the enmeshing of technology with people that Mol 
(2008) describes as central to a logic of care, which must allow both the subjective 
experience of the patient and the situated judgement of the professional to ‘tinker’ in the 
decision making process. However, the ideal of automation inscribed in the algorithm can 
render problematic this ‘qualculative’ enmeshing of qualitative and quantitative information 
(Moser and Law, 2006).  Once the number is produced it enacts a binary – an individual 
 21 
either has AKI or they do not. This binary then produces two possible and divergent courses 
of action for staff. Each alert is documented and counts towards the statistical record of 
instances of AKI both within the hospital and nationally, while each instance of ‘not AKI’ is 
left undetected and not subject to an alert, with additional human resources required to 
investigate whether it might still be a case or not. The binary assumptions of calculative 
logics proliferate, with one binary producing another set: ‘AKI/Not AKI’ is followed up by 
‘appropriate/inappropriate’ actions to be taken by staff (c.f. Peerally et al., 2017).    
When the algorithm detects a possible AKI, the alert also registers instantaneously as a 
‘banner’ on the EPR. This means that every worker looking at a particular individual’s record 
will see a highlighted bar at the top of the screen alerting them to the possible presence of 
AKI. Along with the banner comes a set of prompts. 
So I think the EPR keeps it in focus. So I think it’s a kind of something that underpins 
the education support, the awareness raising. So I think that because it’s there and 
coming at you every time you’re looking at a patient that’s kind of reinforcing us. So 
it’s kind of triggering off those memories about, “oh yeah, well we did the AKI 
learning package the other week and now I know what that means and what that’s all 
about.” So I think the fact that it is high profile within EPR and, you know, there is no 
kind of avoiding that (Q3).  
It follows that blood that does not prompt an alert will make no further appearance on EPR, 
until such time that another sample is taken and the status changes. Blood that is marked as 
AKI becomes a target for communication and intervention, and the EPR ‘triggers’ the 
appropriate staff response. This reinforces the binary function of the algorithm, which 
reduces the complexity of qualitative decision making down to a 1/0 choice. The EPR then 
directs the appropriate steps to be taken for the ‘1s’. Together, the algorithm and the EPR 
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then signal the point at which the number becomes detached from one normative order and 
becomes an active part of another; prompting a surveillance regime and directing particular 
actions, regulating responses and tallying the normal and deviant: 
So if you’re making a decision, so like the pharmacist’s review, so the pharmacist’s 
review conducted within 24 hours of admission or 24 hours of the first AKI alert, 
when you do that review there’s a section on their review document that says; “I’ve 
discussed this with the clinical team”, “I’ve discussed this with…” and you put the 
names of the people that you’ve discussed this with, and; “the actions we’ve agreed 
on are…” and so on and so forth. So that will give you then a kind of audit trail of, 
“what did we do?”, “who did we communicate that with?”, “what actions did 
everybody take?”, so we can actually look at that pathway and say, “did we tread the 
right path for this patient?”, “did we do everything we possibly could, everything that 
best practice dictates we should and are we compliant with the guideline at the same 
time?”(Q3) 
In the above quote the EPR plays a role in developing the relationship between care, risk and 
audit. Organised care is represented as risky (as in the example of process mapping above). 
The EPR also conducts a kind of implicit problematisation, but in addition offers a more 
directive means to ‘improve’ care, by producing an auditable account of the ‘right path’. The 
understanding of ‘good care’ inscribed in the EPR is therefore ‘compliant’ care. The 
implication is that if something goes wrong, an account can be presented through which fault, 
or its absence, can be identified. A further implication is that this kind of ‘process’ data can 
be collected together to tabulate and compare the performance of departments within an 
organisation, or between different organisations. In the last section of our findings, we show 
how the incentive scheme acts as a mechanism to translate the risks associated with this data 
into costs. 
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Decision-making using kidney numbers  
Once practices and the organisational, human and relational processes in which they are 
situated have been materialised into numbers, these numbers participate in new ways in the 
experience out of which they were generated. The adoption of the incentive scheme within 
the hospital provides the empirical material to demonstrate this process. The incentive 
scheme was adopted in April 2015, after which there was a 3 month period during which the 
organisation agreed thresholds with NHS England against which their data would be 
monitored. Data was then counted over four quarters, with the threshold rising up to the pre-
agreed limit by the fourth quarter. The agreement of thresholds is therefore a crucial part of 
the process, and these considerations were high on the agenda of the AKI steering group over 
this period: 
Steering Group May 2015 
Q2 is taking the group through the ‘assurance’ part of the agenda, which at the 
moment is dominated by the incentive scheme. Q1 is concerned that the AKI stages 
are not being recorded, he had thought that EPR should improve this, but so far it 
doesn’t seem to have (he notes this with the EPR technician, to be discussed in more 
detail later on), he also notes that medication reviews are poor (I think he means not 
being done when they should be, rather than being done badly), and that there are 
missing discharge summaries (It is not clear whether this means the whole discharge 
summary is missing, or just the AKI data that is meant to be recorded on them). Q2 
ends with a warning that July will be the start of financial penalties if they don’t meet 
the standard. She sets priorities: EPR and medication review. 
Steering Group June 2015 
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The agenda today is almost entirely assurance (incentive scheme). Q2 once again 
leads the discussion, though this time the lead renal consultant (RC1) also 
contributes. RC1 sets out the pre-agreed thresholds across the four quarters. RC1 
emphasises the importance of ‘aiming low’ in the thresholds, there are some smiles 
around the room at this, but it appears that RC1 is being quite sincere, saying that if 
the organisation don’t comply with these thresholds then they will face financial 
penalties. RC1 finishes by saying that data ‘counts’ from the 1st July (next week). 
In the above excerpts, the incentive scheme directs practice through ‘thresholds’ and 
‘penalties’: thresholds are a conservative guess at what might be achieved in practice. As 
observed above, practice is made up of a number of interacting qualitative and quantitative 
processes, all with multiple contextually sensitive variables. Once the threshold is set, the 
quantitative target directs the practice. Improvements in practice are then driven by the idea 
of ‘penalties’, which associates insufficient improvement with cost. This involves the 
naturalisation of the outcome yet to be achieved – that is, it creates a projection in which the 
full ‘bonus’ that the incentive scheme represents is achieved, and makes this the benchmark 
against which the present is costed. 
In the example of process mapping above, we saw a compressed example of this future-
inversion in practice, when Q1 used the incentive scheme standards as a means to render a 
simplified representation of the hypothetical patient journey, in so doing highlighting areas of 
risk. In the working group meetings that followed the initiation of the incentive scheme, this 
process was stretched out over a period of months, with each new set of numbers prompting 
the further identification and interrogation of problems in practice: 
Steering Group Memo December 2015  
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The AKI incentive scheme figure is currently at 78% and our target is 90% by the end 
of Quarter 4 (March 16).  There is concern that some patients are still falling through 
the net at weekends when discharge information is not updated on EPR.  It may be 
worth looking at the work done by the surgical high dependency unit around out of 
hour’s interventions (urine dip/protein). 
There needs to be exploration about whether EPR could accommodate a drop down 
option for the different repeat blood options we devise with the junior doctors.  
Educating junior doctors is key to getting this right.  We will be talking to Foundation 
Year 1s every 2 weeks prior to their Tuesday teaching session. 
Steering Group Memo March 2016 
We were at 75% in Q3 against a target of 70% and need to reach 90% at Q4. 
The focus is on discharge summaries and the QI team have informed all medical 
directors. 
There are a few things we could look at: 
1. Pharmacy – EPR might miss an opportunity when there is a flag after the 
follow up is completed.   
2. Consultant X’s algorithm on bloods at discharge has been sent to junior 
doctors and pharmacology and is being tested 
3. Query to QI3 re showing the AKI has been resolved on EPR 
4. “Bloods” within 1 week is unlikely to be done by GPs and the incentive 
scheme asks for a “Reasonable Follow-up” 
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As these two excerpts show, the data, whether the organisation is meeting the quarterly 
targets or not, is taken as an opportunity to further interrogate practice. Qualitative judgement 
is then mobilised to suggest further possibilities for the regulation of moment-to-moment 
action. Often this revolves around ‘known’ risks (such as junior doctors, who rotate regularly 
between departments, or situations involving the transfer of information or individuals 
between departments, such as the pharmacy reviews). This search for possible further 
regulation then drives the selection and presentation of data to be shown in EPR, and further 
develops the directives that are deemed necessary to prompt action towards compliance in the 
moment. 
The incentive scheme prompts the organisation to make a set of financial projections, which 
are objectified and turned back onto practice in order to direct improvement. This process 
renders risks as costs – the compliance inscribed in the EPR here is transformed into financial 
compliance. 
The incentive scheme projected a financial future which established a relationship of debt 
within the programme – if the programme was not successful then the organisation would be 
penalised. Therefore, not only can the incentive scheme be shown to be directing the QI 
program, but in so doing, it created a separation of orders, where the ‘narrative’ of the QI 
programme became a speculative attempt to explain the numbers and a performative account 
to maintain commitment on the frontline, while the numbers were detached in order to be 
made public through regional and national reporting networks. 
Discussion 
The financialisation of AKI involves the transformation of discrete episodes of illness, and 
their associated practices, into numbers on an accounting table. This results in a schism, in 
which the numbers of improvement become the means by which organisations can present an 
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external account to be tabulated and compared with other organisations, while the QI 
programme itself becomes a performative narrative to maintain commitment and stability on 
the frontline (c.f. Froud et al., 2006). Our argument is significant for the study of health care 
organisation and points the way to a future research agenda for the study of financialisation in 
this and other public sector domains. 
In the first presentation of data, we used the example of process mapping to show how the 
wards participating in the QI programme were represented as problematic and made a target 
for intervention. In this case, the first step towards the generation of a new normative order 
involved a disordering of the present. In the second presentation of data, we showed how the 
algorithm and electronic patient record worked together to enact a shift from one (qualitative) 
order to another (calculative). This created an auditable account of a compliant care process 
and directed staff actions towards the achievement of it. In the last presentation of data, we 
showed how the incentive scheme translates compliance into finance, by projecting the future 
attainment of a financial goal back upon practice. In so doing it establishes a debt relation 
between the programme and the organisation. In this way financially oriented forms of 
accountability such as the incentive scheme ‘hinge’ between government debt and the daily 
practices of care within hospitals (c.f. du Gay et al., 2012). The economic and political 
narrative of austerity then directs the production of numbers at the organisational level for the 
purposes of finance and accounting. 
Our study contributes to the emerging body of work on financialisation in the public sector 
(du Gay et al., 2012, Froud et al., 2009). Our aim has been to describe the materialisation of 
financial concerns and relationships within the banal everyday of a QI programme for acute 
kidney injury. As quality, safety, and improvement are key everyday operators within all 
public service organisations, we expect our argument to be broadly generalisable to other 
domains within and beyond health care and in other national contexts. Of course, the 
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mechanisms and the translational work they do will be key to specifying these processes 
within different contexts. 
Within the domain of sociological studies of health care quality and safety, we have built 
upon Waring’s (2009) study of the translation of qualitative judgement into quantitative 
organisational arrangements (from care to risk), by showing how these arrangements then go 
to work, both back ‘down’ upon daily care, and ‘up’ to organisational accounting and 
decision making (from risk to cost). This then demonstrates how financialisation moves us 
beyond the familiar tensions of managers versus professionals, as the work of both ends up 
being subjugated by an organisational need to produce improved numbers. This could be read 
as the organisational dimension of the process Waring (2007) describes as adaptive 
regulation, in which medical professionals internalise managerial safety norms even as they 
resist them. Here, beyond both managers and professionals, the idea of ‘safety’ itself was 
being regulated by financial norms, and although it was often clear that individuals were 
aware of this regulation and its drivers – for example, in the widespread criticism we heard of 
the incentive scheme, from both managers and practitioners, and its directive and 
financialised approach – this did not stop individuals directing their energies towards the 
successful achievement of the standards it required (cf. Allen, 2016), or prevent the co-
optation of a set of medical practices by another order (cf. Harrison, 2009). This indicates an 
implicit collective understanding that the macro processes described in the early part of this 
paper are treated as inevitable, and a kind of work we can refer to as organisational 
caretaking is directed to ensure organisational survival. However, this very same work 
further reproduces and naturalises those same conditions. Therefore, as the numbers produced 
by this work appear increasingly independent, so too the importance of adaptation, resistance 
and other kinds of human agency are diminished.  
Conclusion 
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Our analysis has extended the literature on financialisation to open up a new way of looking 
at health care organisation. Almost half a century after the introduction of new public 
management was justified with reference to the need for entrepreneurialism, individuals 
within public service organisations continue to live with, enact and internalise the logics of 
markets and managerialism. Producing auditable accounts of care, reducing costs, and 
limiting human autonomy now appear as matters of fact. 
Among the possible consequences of the transformation we have described here is the neglect 
of what Mol (2008) describes as the enmeshed and entangled practice of care. This kind of 
practice is essential for the increasingly complex meeting of subjectivity, technology and 
politics experienced in contemporary health care organisation. Financialisation can therefore 
threaten healthcare. Caring practices in health will not simply stop. Human agency and the 
professional ethos continue to be important, but they are increasingly being rendered 
organisationally illegitimate, wasteful, risky and costly through financialisation. This is 
compounded by further decreases in public expenditure on healthcare, which threaten the 
ability of staff to ‘go beyond’ in the manner that care and their professional norms demand. 
Possible solutions to this problem are beyond the scope of this paper but problematising the 
present, as we have, is a helpful starting point for thinking about how to generate alternative 
futures in the present. 
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